SVA-18615-53808
3 vaccinations
6 coded responses
23 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 231 / VA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2020-12-26
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-23
- 2021-01-30
-
2021-02-08
Survey response — day 28, dose 2MedDRA: Fatigue, Respiratory tract congestion, Sneezing — Feeling: FairFree text: Sneezing, mild fatigue, very mild congestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Survey response — day 35, dose 2MedDRA: Rhinorrhoea, Sinus congestion, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, sinus congestion, sneezing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — day 42, dose 2MedDRA: Rhinorrhoea, Sneezing — Feeling: FairFree text: Runny nose, sneezing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
-
2021-07-11
Survey response — 6 months, dose 2MedDRA: Headache, Sinus headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headaches that start at the base of my neck and also go into my sinuses.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2022-01-09
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Currently have COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-11
Call successfulParticipant prefers to complete VAERS report online
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising at injection site
Release 3 — day 28, dose 2
Symptoms: Sneezing, mild fatigue, very mild congestion.
Release 4 — day 35, dose 2
Symptoms: Runny nose, sinus congestion, sneezing.
Release 4 — day 42, dose 2
Symptoms: Runny nose, sneezing.
Release 9 — 6 months, dose 2
Symptoms: Headaches that start at the base of my neck and also go into my sinuses.
Release 10 — 12 months, dose 2
Symptoms: Currently have COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
| SD | Sinus headache | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release